vaxgen inc fighting the aids epidemic center for social innovation csi skip to content center for social innovation csi center for social innovation az index find people visit admissions faculty & research alumni recruiters & companies news about the gsb search csi search the gsb home research by topic healthcare vaxgen inc fighting the aids epidemic home research by topic arts culture and religion corporate social responsibility economic development education environment government leadership healthcare human rights nonprofit management philanthropy responsible investing social entrepreneurship student programs executive programs gsb social innovators community engagement events about csi more content blog social innovation podcast e newsletter videos follow us icon face book icon twitter vaxgen inc fighting the aids epidemic academic case study by margaret l eaton jennifer wilds betty pang published 2009 topics healthcare tweet the vaxgen inc case details the efforts of vaxgen and its president don francis to obtain approval to conduct phase iii clinical trials in thailand for aidsvax an experimental vaccine designed to protect against the human immunodeficiency virus hiv the virus that causes aids francis must grapple with ethical questions such as will aidsvax will be effective enough to warrant the involvement of thousands of subjects in clinical trials and what type of compensation or treatment if any should be offered to volunteer subjects in third world countries where the standard for aids treatment is much lower than in the united states gsb faculty students and staff only may view pdf document authorization required paper copy you may purchase this case from harvard business publishing case no bme1 explore this topic community centered planning admissions faculty & research alumni recruiters & companies giving executive education news about the gsb copyright 2009 stanford graduate school of business site help terms of use & policies stanford university
